Buy These 3 Dividend Stocks RIGHT NOW At 52-Week Lows 💰
3 extracted signals · 0 resolved · 3 still active
Ryne WilliamsIndependent analyst profile- Source published
- 25 Oct 2026, 22:58 UTC
- Recorded by Tahlil Plus
- 26 Oct 2026, 04:42 UTC
AI-generated source summary
The analysis focuses on three dividend-paying stocks currently trading near their 52-week lows, suggesting potential buying opportunities. Agree Realty Corporation (ADC) is down over 17% in the last three months, trading at $66.70, with a target price inferred around $75.00 and a fail bound set at $60.00. It boasts a 5.04% dividend yield and a 13-year dividend growth streak, with a CAGR of 5.1% over 13 years. Booking Holdings Inc. (BKNG) is also experiencing a downturn, down 12.19% in the last three months, currently at $155.83. The inferred target is $170.00, with a fail bound at $140.00. BKNG has a 1.06% dividend yield and a 1-year dividend CAGR of 9.4%. Lastly, The Clorox Company (CLX) is trading at $86.40, down 9.58% over the past three months. The inferred target for CLX is $95.00, with a fail bound at $80.00. CLX offers a 5.90% dividend yield and has a long history of dividend growth, with a 2.1% CAGR over 49 years, indicating stability despite recent price declines.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
3 signals remain active.
Ryne Williams
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.